Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models

Ergang Wang, Kun Xiang, Yun Zhang, Xiao-Fan Wang

Open source

DOI
10.1016/j.jncc.2022.10.001
Published
2022-12
Container
Journal of the National Cancer Center
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jncc.2022.10.001,
  title = {Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models},
  author = {Ergang Wang and Kun Xiang and Yun Zhang and Xiao-Fan Wang},
  year = {2022},
  journal = {Journal of the National Cancer Center},
  doi = {10.1016/j.jncc.2022.10.001},
  url = {https://doi.org/10.1016/j.jncc.2022.10.001}
}

RIS

TY  - JOUR
TI  - Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
AU  - Ergang Wang
AU  - Kun Xiang
AU  - Yun Zhang
AU  - Xiao-Fan Wang
PY  - 2022
JO  - Journal of the National Cancer Center
DO  - 10.1016/j.jncc.2022.10.001
UR  - https://doi.org/10.1016/j.jncc.2022.10.001
ER  - 

APA

Wang, E., Xiang, K., Zhang, Y., & Wang, X. (2022). Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models. Journal of the National Cancer Center. https://doi.org/10.1016/j.jncc.2022.10.001

Source records